Patents Assigned to ZENJI RESEARCH LABORATORIES
  • Substituted [5,6]cyclic-4(3H)-pyrimidinones as anticancer agents
    Patent number: 10745410
    Abstract: The present invention relates to novel substituted [5,6]cyclic-4(3H)-pyrimidinone compounds of formula (I) and their preparation methods. (I) In particular, the present invention relates to novel substituted [5,6]cyclic-4(3H)-pyrimidinone compounds useful as inhibitors of protein kinases, specifically CDC7 (cell division cycle 7) inhibitors.
    Type: Grant
    Filed: May 8, 2018
    Date of Patent: August 18, 2020
    Assignee: ZENJI RESEARCH LABORATORIES
    Inventor: Hai-Jun Zhang